 |
Previous Article | Next Article 
The Journal of Neuroscience, July 15, 2001, 21(14):4987-4995
Dishevelled Regulates the Metabolism of Amyloid Precursor Protein
via Protein Kinase C/Mitogen-Activated Protein Kinase and c-Jun
Terminal Kinase
A.
Mudher1,
S.
Chapman1,
J.
Richardson3,
A.
Asuni1,
G.
Gibb1,
C.
Pollard1,
R.
Killick1,
T.
Iqbal1,
L.
Raymond2,
I.
Varndell4,
P.
Sheppard4,
A.
Makoff2,
E.
Gower3,
P. E.
Soden3,
P.
Lewis5,
M.
Murphy5,
T. E.
Golde5,
H. T.
Rupniak3,
B. H.
Anderton1, and
S.
Lovestone1, 2
Departments of 1 Neuroscience and
2 Psychiatry, Institute of Psychiatry, King's College
London, London SE5 8AF, United Kingdom, 3 Glaxo Wellcome,
Stevenage, Herts, SG1 2NY, United Kingdom, 4 Affiniti
Research Products Limited, Mamhead, Exeter, EX6 8HD, United Kingdom,
and 5 Mayo Clinic Jacksonville, Department of Neuroscience,
Florida 32224
Alzheimer's disease (AD) is a disorder of two pathologies: amyloid
plaques, the core of which is a peptide derived from the amyloid
precursor protein (APP), and neurofibrillary tangles composed of highly
phosphorylated tau. Protein kinase C (PKC) is known to increase
non-amyloidogenic -secretase cleavage of APP, producing secreted APP
(sAPP ), and glycogen synthase kinase (GSK)-3 is known to increase
tau phosphorylation. Both PKC and GSK-3 are components of the
wnt signaling cascade. Here we demonstrate that overexpression
of another member of this pathway, dishevelled (dvl-1), increases
sAPP production. The dishevelled action on APP is mediated via both
c-jun terminal kinase (JNK) and protein kinase C
(PKC)/mitogen-activated protein (MAP) kinase but not via p38 MAP
kinase. These data position dvl-1 upstream of both PKC and JNK, thereby
explaining the previously observed dual signaling action of dvl-1.
Furthermore, we show that human dvl-1 and wnt-1 also reduce the
phosphorylation of tau by GSK-3 . Therefore, both APP metabolism and
tau phosphorylation are potentially linked through wnt signaling.
Key words:
dishevelled; Alzheimer's disease; amyloid
precursor protein; PKC; JNK; GSK-3; tau; wnt
Copyright © 2001 Society for Neuroscience 0270-6474/01/21144987-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
G. V. De Ferrari, A. Papassotiropoulos, T. Biechele, F. Wavrant De-Vrieze, M. E. Avila, M. B. Major, A. Myers, K. Saez, J. P. Henriquez, A. Zhao, et al.
Common genetic variation within the Low-Density Lipoprotein Receptor-Related Protein 6 and late-onset Alzheimer's disease
PNAS,
May 29, 2007;
104(22):
9434 - 9439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C. Kraemer, J. K. Burgess, J. H. Chen, J. H. Thomas, and G. D. Schellenberg
Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans
Hum. Mol. Genet.,
May 1, 2006;
15(9):
1483 - 1496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Mi, P. J. Dolan, and G. V. W. Johnson
The Low Density Lipoprotein Receptor-related Protein 6 Interacts with Glycogen Synthase Kinase 3 and Attenuates Activity
J. Biol. Chem.,
February 24, 2006;
281(8):
4787 - 4794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. H. Stoothoff, J.-H. Cho, R. P. McDonald, and G. V. W. Johnson
FRAT-2 Preferentially Increases Glycogen Synthase Kinase 3{beta}-mediated Phosphorylation of Primed Sites, Which Results in Enhanced Tau Phosphorylation
J. Biol. Chem.,
January 7, 2005;
280(1):
270 - 276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Sawamura, M. Ko, W. Yu, K. Zou, K. Hanada, T. Suzuki, J.-S. Gong, K. Yanagisawa, and M. Michikawa
Modulation of Amyloid Precursor Protein Cleavage by Cellular Sphingolipids
J. Biol. Chem.,
March 19, 2004;
279(12):
11984 - 11991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Sheldahl, D. C. Slusarski, P. Pandur, J. R. Miller, M. Kuhl, and R. T. Moon
Dishevelled activates Ca2+ flux, PKC, and CamKII in vertebrate embryos
J. Cell Biol.,
May 26, 2003;
161(4):
769 - 777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Hartmann, B. de Strooper, L. Serneels, K. Craessaerts, A. Herreman, W. Annaert, L. Umans, T. Lubke, A. Lena Illert, K. von Figura, et al.
The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for {alpha}-secretase activity in fibroblasts
Hum. Mol. Genet.,
October 2, 2002;
11(21):
2615 - 2624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Taru, Y. Kirino, and T. Suzuki
Differential Roles of JIP Scaffold Proteins in the Modulation of Amyloid Precursor Protein Metabolism
J. Biol. Chem.,
July 19, 2002;
277(30):
27567 - 27574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Savage, Y.-G. Lin, J. R. Ciallella, D. G. Flood, and R. W. Scott
Activation of c-Jun N-Terminal Kinase and p38 in an Alzheimer's Disease Model Is Associated with Amyloid Deposition
J. Neurosci.,
May 1, 2002;
22(9):
3376 - 3385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Killick, C. C. Pollard, A. A. Asuni, A. K. Mudher, J. C. Richardson, H. T. Rupniak, P. W. Sheppard, I. M. Varndell, J.-P. Brion, A. I. Levey, et al.
Presenilin 1 Independently Regulates beta -Catenin Stability and Transcriptional Activity
J. Biol. Chem.,
December 14, 2001;
276(51):
48554 - 48561.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|